Putnam Investments’s AngioDynamics ANGO Stock Holding History

Putnam Investments’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$384K	Sell	49,027 -1,549	-3%	-$10.7K	﹤0.01%	1025
2023 Q3	$370K	Buy	50,576 +9,294	+23%	+$77.3K	﹤0.01%	995
2023 Q2	$431K	Buy	41,282 +11,088	+37%	+$107K	﹤0.01%	956
2023 Q1	$312K	Buy	30,194 +1,876	+7%	+$24K	﹤0.01%	1077
2022 Q4	$390K	Buy	28,318 +8,236	+41%	+$115K	﹤0.01%	996
2022 Q3	$410K	Sell	20,082 -363	-2%	-$7.97K	﹤0.01%	977
2022 Q2	$395K	Sell	20,445 -250	-1%	-$5.12K	﹤0.01%	1000
2022 Q1	$446K	Buy	20,695 +892	+5%	+$20.2K	﹤0.01%	1043
2021 Q4	$546K	Buy	+19,803	New	+$546K	﹤0.01%	951

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Putnam Investments's ANGO Position: Q4 2023 in Review

Putnam Investments reduced its AngioDynamics (ANGO) stake by 3.1% in Q4 2023, selling an estimated $10.7K and leaving 49,027 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

Putnam Investments first reported a position in ANGO in Q4 2021 and has held it in 9 quarters since. The position peaked at $546K in Q4 2021. 150 funds tracked by Wall St. Rank hold ANGO as of Q4 2023.

Putnam Investments held 49,027 shares of AngioDynamics worth $384K as of Q4 2023.
Putnam Investments sold 1,549 AngioDynamics shares in Q4 2023, an estimated $10.7K.
AngioDynamics made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1025 holding.
Putnam Investments first reported a position in AngioDynamics in Q4 2021 and has held it in 9 quarters since.
Putnam Investments's AngioDynamics position peaked at $546K in Q4 2021.
150 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.